USA Financial Formulas’s Emergent Biosolutions EBS Stock Holding History

USA Financial Formulas’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-8,885	Closed	-$585K	–	185
2018 Q4	$585K	Buy	+8,885	New	+$573K	0.15%	111
2018 Q3	–	Sell	-5,865	Closed	-$309K	–	305
2018 Q2	$309K	Sell	5,865 -20	-0.3%	-$1.04K	0.08%	242
2018 Q1	$310K	Buy	+5,885	New	+$293K	0.07%	242
2015 Q4	–	Sell	-9,006	Closed	-$257K	–	103
2015 Q3	$257K	Buy	+9,006	New	+$297K	0.17%	85

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

USA Financial Formulas's EBS Position: Q1 2019 in Review

USA Financial Formulas sold out of Emergent Biosolutions (EBS) in Q1 2019, closing a stake of 8,885 shares — an estimated $585K sold.

USA Financial Formulas first reported a position in EBS in Q3 2015 and held it in 4 quarters. The position peaked at $585K in Q4 2018. 272 funds tracked by Wall St. Rank hold EBS as of Q1 2019.

USA Financial Formulas reported no remaining Emergent Biosolutions position as of Q1 2019 after selling out during the quarter.
USA Financial Formulas sold 8,885 Emergent Biosolutions shares in Q1 2019, an estimated $585K.
USA Financial Formulas first reported a position in Emergent Biosolutions in Q3 2015 and held it in 4 quarters.
USA Financial Formulas's Emergent Biosolutions position peaked at $585K in Q4 2018.
272 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2019.

Based on USA Financial Formulas's 13F filing for Q1 2019, filed 14 May 2019.